Home » South Korea FDA, USP Forge Pact to Improve Drug Safety, Quality
South Korea FDA, USP Forge Pact to Improve Drug Safety, Quality
May 10, 2012
Looking to increase pharmaceutical trade with the U.S. and improve its drug manufacturing standards, the South Korea Food and Drug Administration (KFDA) April 2 signed a memorandum of understanding (MOU) with the U.S. Pharmacopeial Convention (USP).
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor